Vitro. de Full Year 2023 Earnings EPS US0.04 - Simply Wall St
| VITROA Stock | MXN 8.95 0.07 0.79% |
About 52% of Vitro SAB's investor base is interested to short. The analysis of current outlook of investing in Vitro SAB de suggests that many traders are impartial regarding Vitro SAB's prospects. The current market sentiment, together with Vitro SAB's historical and current headlines, can help investors time the market. In addition, many technical investors use Vitro SAB de stock news signals to limit their universe of possible portfolio assets.
Vitro |
Vitro. de Full Year 2023 Earnings EPS US0.04 Simply Wall St
Read at news.google.com
 |
Vitro SAB Fundamental Analysis
We analyze Vitro SAB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Vitro SAB using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Vitro SAB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash And Equivalents
Cash And Equivalents Comparative Analysis
Vitro SAB is currently under evaluation in cash and equivalents category among its peers. Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Vitro SAB de Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Vitro SAB stock to make a market-neutral strategy. Peer analysis of Vitro SAB could also be used in its relative valuation, which is a method of valuing Vitro SAB by comparing valuation metrics with similar companies.
Peers
Vitro SAB Related Equities
| COLLADO | G Collado | 0.00 |
| ||
| PV | Pea Verde | 0.00 |
| ||
| BEVIDESB | Farmacias Benavides | 0.00 |
| ||
| SCCO | Southern Copper | 0.00 |
| ||
| MINSAB | Grupo Minsa | 0.00 |
| ||
| ALFAA | Alfa SAB | 0.07 |
| ||
| SORIANAB | Organizacin Soriana | 0.07 |
| ||
| AUTLANB | Compaa Minera | 0.43 |
| ||
| ELEKTRA | Grupo Elektra | 0.97 |
|
Complementary Tools for Vitro Stock analysis
When running Vitro SAB's price analysis, check to measure Vitro SAB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vitro SAB is operating at the current time. Most of Vitro SAB's value examination focuses on studying past and present price action to predict the probability of Vitro SAB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vitro SAB's price. Additionally, you may evaluate how the addition of Vitro SAB to your portfolios can decrease your overall portfolio volatility.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |